Erythropoietin (Epo) is one of the physiologically important genes whose transcription is up-regulated by hypoxia. Our laboratory previously proposed that the sensor of this event is a heme protein which turns over rapidly. We have investigated the effects of four inhibitors of heme synthesis (4,6-dioxoheptanoic acid (DHA), isoniazid (INH), N-methyl protoporphyrin IX (MPP), and deferoxamine mesylate (DSF)) on hypoxia-, cobalt-, and DSF-induced erythropoietin (Epo) mRNA expression, heme biosynthesis, and cell viability in Hep3B cells. DHA (0.1^1.0 mM) inhibited heme biosynthesis more than 85%, but did not suppress Epo mRNA expression. Epo mRNA expression was inhibited only at higher concentrations of DHA (2, 4 mM) which also inhibited cell viability. No suppression of Epo mRNA expression by INH was observed at doses known to inhibit heme biosynthesis. MPP did not suppress Epo mRNA expression although it showed an inhibitory effect on heme biosynthesis without any decreased cell viability. 130 WM DSF, a dose which inhibited heme biosynthesis without cell toxicity, suppressed hypoxia-induced Epo mRNA expression, but enhanced cobalt-induced Epo mRNA expression. These results show that although the oxygen sensor is probably a heme protein it does not turn over rapidly. Therefore, cobalt is unlikely to act by substituting for heme iron. ß
Introduction
Almost all living organisms from bacteria to human beings utilize oxygen in order to acquire e¤cient chemical energy. Therefore, the survival of cells and organisms depends upon some type of sensitive oxygen sensing system. In fact a number of physiologically important genes are induced by hypoxia. These include erythropoietin (Epo), tyrosine hydroxylase, vascular endothelial growth factor, and genes involved in glucose metabolism [1] . Currently there is considerable interest in the mechanism of oxygen sensing and transduction of signal that e¡ects expression of these and other oxygen responsive genes.
Epo, a glycoprotein hormone produced in the kidney and liver, regulates erythrocyte production. Epo production is strongly induced not only by hypoxia, but also by certain divalent metals including cobalt (Co 2 ), nickel, and manganese. The expression of Epo in human hepatoma cell lines such as Hep3B cells or HepG2 cells [2] has frequently been used as an e¡ective model for studying the oxygen sensor. Goldberg et al. [3] have proposed that oxygen is sensed by binding to a heme protein with a resulting change in conformation. In oxygenated cells, the oxy form does not stimulate Epo induction whereas, at low oxygen tension, the deoxy form triggers increased expression of the Epo gene. In this model, the ability of cobalt to simulate hypoxia was explained by the substitution of Co 2 for ferrous iron in the porphyrin ring, thereby locking the heme protein in the deoxy conformation just as at low oxygen tension. This heme protein model was supported by evidence that two heme synthesis inhibitors, 4,6-dioxoheptanoic acid (DHA, succinylacetone) and deferoxamine mesylate (DSF), reduced hypoxia-or Co 2 -induced Epo induction in Hep3B cells [3] . DHA is a potent and speci¢c inhibitor of N-aminolevulinic acid (ALA) dehydratase, the enzyme which converts two molecules of ALA to porphobilinogen. However, the concentration of DHA that was used (2 mM) is considerably higher than that previously shown to inhibit ALA dehydratase activity and heme biosynthesis [4^6] . Therefore, the reduced Epo production in Hep3B cells treated with DHA reported by Goldberg et al. might be due to a toxic e¡ect on cells rather than its inhibitory e¡ect on heme biosynthesis. In fact, Srinivas et al. [7] recently reported that DHA, at a concentration su¤cient to inhibit heme synthesis, failed to blunt hypoxic induction of a reporter gene. In order to resolve this issue it is necessary to develop dose^response relationships to determine the impact of heme synthesis inhibitors on Epo induction versus cell viability. In this paper we tested not only DHA but also three additional heme synthesis inhibitors: isoniazid (INH), Nmethyl protoporphyrin IX (MPP) and DSF, and have monitored the e¡ects of these inhibitors on Epo mRNA expression, heme biosynthesis and cell viability in Hep3B cells.
Materials and methods

Cell culture
Hep3B cells were maintained in K-modi¢ed Eagle's medium (Gibco BRL) supplemented with 10% fetal bovine serum (Gibco BRL) at 37³C. At the initiation of each experiment, cells were resuspended in the medium at a density of 2.5U10 5 /ml and after preincubation for 24 h, heme synthesis inhibitors, DHA, INH, DSF and MPP were added and the incubation was continued for another 24 h. DHA, INH and DSF were purchased from Sigma, and MPP was obtained from Porphyrin Products. Cells were cultured either under normoxic conditions (95% air and 5% CO 2 ), or, in some experiments, were exposed to hypoxia (1% O 2 , 94% N 2 , and 5% CO 2 ) in an Espec BNP-210 incubator.
Ribonuclease protection analysis
We used a previously described [8] construct (pGRm) in which a 203 bp long DNA fragment of genomic human Epo (GenBank accession number M11319, nucleotides 2565^2767) was inserted into pGEM3Zf(+). The Epo gene in this construct has been`marked' by site-directed mutagenesis at three positions in the coding region of Exon 5 [8] . As a result, after hybridization of this marked riboprobe to endogenous Epo mRNA, RNase digestion yields two major fragments of 75 bp and 61 bp. RNA was puri¢ed from Hep3B cells by using TRI ZOL Reagent (Gibco BRL). The concentrations of total RNA was calculated by measuring the absorbance at 260 nm and 280 nm. The intactness of each RNA sample was con¢rmed by visualization on a UV transilluminator after running small aliquots on a 1% agarose gel. Sixty Wg of each RNA sample was mixed with Epo riboprobe labeled by K-[ 32 P]CTP (NEN) and hybridized at 55³C overnight. The hybridized RNAs were digested by RNase and electrophoresed in 10% polyacrylamide gel as described previously [8] . The dried gel was analyzed by a phosphoimager (Molecular Dynamics).
Assay of heme biosynthesis
The newly synthesized heme in Hep3B cells was measured as described by Shedlofsky et al. [9] . After preincubation in 3.5-cm culture dishes, Hep3B cells were further incubated for 24 h with the heme precursor N-[
14 C]ALA (NEN) (0.2 WCi/dish). Cold N-ALA (20 WM) was also added to the culture medium as the carrier for N-[
14 C]ALA. At the end of incu-bation, the total heme was extracted from the cells by using acetone^HCl and diethyl ether. With the exception of experiments testing the e¡ects of INH, the incorporation of radioactivity into the extracted heme provided a measure of heme biosynthesis.
Cell viability assay
We used a modi¢ed MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay for evaluating cell viability [10] . One-tenth volume of MTT solution (Sigma) was added to the media of cultured cells and incubated at 37³C for 1 h. At the end of incubation period the media was removed from the culture plate and the converted dye was solubilized with DMSO. Cell viability was determined from the absorbance of the dye at 570 nm with background subtraction at 630 nm.
Results
We treated Hep3B cells for 24 h in a normoxic atmosphere with four types of heme synthesis inhibitors, DHA, INH, MPP and DSF. We then cultured the cells under either hypoxia, or in the presence of 100 WM Co 2 , or 130 WM DSF for 6 h. We determined Epo mRNA expression in these cells by ribonuclease protection assay (RPA) and measured heme biosynthesis and viability of the cells.
DHA
As shown in Fig. 1A , 100 WM and 1 mM of DHA inhibited heme biosynthesis in Hep3B cells more than 85%, consistent with previous reports [4^6]. However, 1 mM of DHA suppressed hypoxia-, Co 2 -and DSF-induced Epo mRNA expression by no more than 20% (Fig. 1B) . We observed strong diminution of Epo mRNA expression by DHA only at higher concentrations (2 and 4 mM). This result is also consistent with previously reported results on the inhibition of Epo production, assayed by RIA, at 2 mM DHA [3] . However, cell viability was clearly decreased at these higher doses of DHA by morphologic observation (not shown) as well as by MTT assay (Fig. 1C) . These results indicate that the suppression of Epo mRNA induction by DHA at 2 mM was not due to inhibition of heme biosynthesis, but rather to cell toxicity.
INH
INH inhibits pyridoxal phosphate, an essential co- factor of ALA synthase. In rabbit reticulocytes, 1 mM INH causes a 70% suppression of incorporation of 59 Fe into heme [11] . In Hep3B cells, 1^20 mM INH had no e¡ect on the induction of Epo mRNA by hypoxia, cobalt or DSF (Fig. 2B) . Because of its site of inhibition, INH would not be expected to a¡ect the incorporation of [
14 C]ALA into heme. The modest suppression which we observed at high concentrations of INH (10, 20, 50 mM) ( Fig. 2A) is probably a non-speci¢c toxic e¡ect since cell viability was also impaired to about the same extent (Fig.  2C ).
MPP
MPP is a powerful inhibitor of ferrochelatase, the ¢nal enzyme in the heme biosynthetic pathway, catalyzing the insertion of ferrous iron into protoporphyrin IX to form protoheme [12, 13] . As shown in Fig. 3 , in Hep3B cells, MPP, at concentrations ranging from 0.05 Wg/ml up to 5 Wg/ml (0.09^9 WM), had a dose-dependent inhibitory e¡ect on heme biosynthesis without any cell toxicity. Even at 80% inhibition observed with the highest dose (5 Wg/ml), MPP had no e¡ect on cell viability or on induction of Epo mRNA by hypoxia, Co 2 or DSF. These results again show that Epo can be robustly induced despite strong inhibition of heme biosynthesis.
DSF
DSF, an iron-chelating agent, is an inducer of Epo [14] . DSF is also an inhibitor of heme synthesis, preventing protoporphyrin from being converted to heme by removing the iron that is normally incorporated into the porphyrin ring [15, 16] . DSF showed dose-dependent inhibition of heme biosynthesis (Fig.  4A ) without obvious cell toxicity (Fig. 4C) . At the highest concentration tested (130 WM), DSF inhibited hypoxia-induced Epo mRNA expression by about 80% (Fig. 4B) , consistent with earlier measurements of Epo protein [2] . However, DSF had no e¡ect on the induction of Epo mRNA by cobalt.
Discussion
In these experiments, Epo mRNA was monitored as an index of cellular response to hypoxia. This induction of Epo mRNA depends on an intact and functional oxygen sensing and signaling pathway. We have investigated the role of heme synthesis in this process by using four compounds having di¡er-ent inhibitory mechanisms. We could not observe any relationship between suppression of Epo induction and heme biosynthesis inhibition. We previously reported that a heme synthesis inhibitor, DHA, reduced hypoxia-and Co 2 -induced Epo production in Hep3B cells [3] . However, in Fig. 1 we present evidence that DHA suppresses Epo induction by virtue of cell toxicity rather than through inhibition of heme synthesis.
Among the four heme inhibitors, only DSF showed a dose-dependent suppressive e¡ect on hypoxia-induced Epo mRNA expression with intact cell viability. In contrast, MPP, which, like DSF, blocks conversion of protoporphyrin to heme, had no e¡ect on Epo induction. Because DSF has contradictory e¡ects on Epo induction by hypoxia versus cobalt, interpretation of this result is di¤cult. Through chelating iron, DSF can a¡ect not only heme synthesis but also Fenton chemistry which is thought to play an important role in hypoxic signaling, upon which Epo induction depends [1] . Our ¢nding that DSF suppresses hypoxic induction of Epo but has no effect on Co 2 induction is di¤cult to reconcile with recent models of oxygen sensing and signal transduction.
In 1988, Goldberg et al. proposed that Co 2 and other transition metals (Ni 2 and Mn 2 ) induced Epo expression by substituting for the iron atom in a heme protein which they proposed to be the oxygen sensor. This suggestion was based on the fact that these substituted metalloporphyrins either have a very low a¤nity for oxygen (Co 2 -heme) or fails to bind oxygen at all (Ni 2 -heme, Mn 2 -heme). This Our results provide insight into the mechanism by which certain transition metals such as Co 2 mimic hypoxia, but they in no way negate the contention that the oxygen sensor is a heme protein. The fact that nitric oxide [19^21] and carbon monoxide, at high concentration [3, 20, 21] , suppresses hypoxic induction of Epo and the hypoxia-inducible transcription factor HIF-1 is consistent with the oxygen sensor being a heme protein.
